Reply
Clin Gastroenterol Hepatol
.
2018 May;16(5):783-784.
doi: 10.1016/j.cgh.2018.01.017.
Authors
Thomas Berg
1
,
Daniel Seehofer
2
,
Thorsten Kaiser
3
Affiliations
1
Section of Hepatology, Department of Gastroenterology and Rheumatology, University Hospital Leipzig, Germany.
2
Department of Visceral, Transplant, Thoracic and Vascular, Surgery, University Hospital Leipzig, Germany.
3
Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Germany.
PMID:
29678239
DOI:
10.1016/j.cgh.2018.01.017
No abstract available
Publication types
Letter
Comment
MeSH terms
End Stage Liver Disease*
Humans
Interleukin-6*
Substances
Interleukin-6